CORPORATE GOVERNANCE:

1) PHILOSOPHY:

Colinz Laboratories Ltd., has always strived to attain highest levels of transparency and accountability in all its operation and in its interactions with Shareholders, Government depts. creditors etc. Hence the Company has taken all appropriate steps to comply with the provisions of the prescribed Corporate Governance Code within the stipulated time.

2) BOARD OF DIRECTORS:

   (a) Composition, Category of Directors and their other directorships as on 31-03-2011:

Name of the Director Category of Directorship No. of Directorships in the public companies
Dr. Mani L. S. Chairman & Managing Director (Executive, Promoter) None
Shri. N. K. Menon Whole-Time Director (Executive) None
CA Vasant K. Bhat Non-Executive, Independent None
Shri. A. Krishna Kumar Non-Executive, Independent None
Name Designation Category of Directorship
CA Vasant K. Bhat Chairman Non-Executive, Independent
Shri. A.Krishnakumar Member Non-Executive, Independent
Dr. Mani L. S. Member Executive, Promoter

 

Company’s Registrar and share transfer agents are:-

b) Remuneration Committee and Policy :

The non-mandatory requirement of setting up of a remuneration committee for remuneration of executive directors has not been adopted considering the nature and the size of the Company. The Board of Directors determines the remuneration payable to the Executive Directors  taking into account their qualifications, experience, expertise and contribution.

c) Investors Grievance Committee :

The Board has constituted an Investors Grievance Committee which looks into shareholders and investors grievances.

Following are the members of the Committee :

Name Designation Category of Directorship
CA Vasant K. Bhat Chairman Non-Executive, Independent
Dr. L. S. Mani Member Executive, Promoter

 

Compliance Officer : CA Vasant K. Bhat.

4. SHAREHOLDERS :

a) Means of  Communication

The quarterly, half yearly and annual audited financial results of the Company are sent to the stock exchange immediately after they are approved by the Board. The results are published in accordance with the guidelines of the Stock Exchange.

b) Share Transfers :

As per SEBI circular D & CC/FITTC/CIR-15/2002 dated 27-12-2002 the Company should have a common agency for share registry work. Accordingly, the Company has appointed  M/s. Bigshare Services Pvt. Ltd., E-2/3, Ansa Industrial Estate, Sakivihar Road, Saki Naka, Andheri (E), Mumbai - 400072, as Common Agency for share registry work.

c) General Body Meetings :

The Annual General Meetings are normally held at the Registered Office of the company, before the time limit stipulated in accordance with the Companies Act and other applicable provisions.

d) Financial Calendar.

Financial year: 1st April to 31st March.

The tentative dates for declaration of un-audited/audited results will be as follows:

Quater ending 30th June -- before 31st July.

Quater ending 30th September -- before 31sr October.

Quater ending 31st December -- before 31st January.

Quater ending March and Audited results for the year ended March -- before 31st May

e) Listing in Stock exchange and stock code.

The shares of the company are listed in The Stock Exchange, Mumbai.

Code of the company: 531210.

The ISIN Number alloted to the Company for demat of shares are as under:

NSDL - INE923C01011.

CDSL - INE923C01011.

f) Share Tranfer System.

The Company has appointed M/s. Bigshare Services Pvt. Ltd., E/2/3 Ansa Industrial Estate, Sakivihar Road, Saki Naka, Andheri (E), Mumbai-400072, as Registrar and Tranfer Agents.

Tel. No. 022-28470652/53

Fax: 022-28475207.

Email: bigshare@bom7.vsnl.net.in

Contact:
A/101, Pratik Estate,
Mulund Link Road,
Next to Fortis Hospital,
Mumbai-400078.
Tel.: 91-22-25668002/3
Fax: 91-22-25668006.
Email: cllfindoc@yahoo.com
Website:www.findoc-cll.in
Email:info@findoc-cll.in